Chief Executive Officer of SINOMED. “BuMA Supreme is just one piece of our overall drug-eluting platform strategy and we are heavily investing in clinical trials to show the long-term benefits of this …
SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent
SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent
Leave a reply